Our study is double blinded and the placebo requires an expiry extension of an additional 8 months. Whilst we have the certificate of intermediate release/confirmation that the retest parameters have been met, this will give the product a 68 month shelf life. The IMPD includes a 60 month shelf life. The extension is only required for the placebo until further placebo has been manufactured. Please could someone advise if an amendment is required?
